Nureca Limited has informed the Exchange regarding Appointment of Ms A. Arora and company as secretarial Auditor of the company w.e.f. April 01, 2025 for a period of 5 years.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited's board, at its May 5, 2025 meeting, approved audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2025 with an unmodified opinion from statutory auditors B S R & Co. LLP. The board appointed M/s Singhi & Co. as the new Statutory Auditor for 5 years (replacing B S R & Co. whose term is ending at the 9th AGM), M/s MGSG and Associates as Internal Auditor for FY26, and M/s A. Arora & Company as Secretarial Auditor for 5 years (FY26–FY30). The board gave in-principle approval to merge wholly owned subsidiary Nureca Technologies Private Limited (FY25 revenue Rs. 228.14 million, net worth Rs. 53.94 million) with Nureca Limited (FY25 standalone revenue Rs. 1,146.40 million, net worth Rs. 1,917.38 million). The merger will not change shareholding as no new shares will be issued. Four directors — Ms. Charu Singh, Ms. Ruchita Agarwal, Mr. Vijay Kumar Sharma (all Independent Directors) and Mr. Rajinder Sharma (Whole-time Director) — were re-appointed for second 5-year terms, and Mr. Saurabh Goyal was re-appointed on retire-by-rotation. The 9th AGM is set for June 16, 2025.
These are largely routine governance and compliance actions with no material negative implications for shareholders. The auditor change is a scheduled rotation rather than a mid-term exit, the subsidiary merger is administrative (wholly owned, no share issuance or dilution), and the director re-appointments signal board continuity. The standalone results reportedly show a net loss while consolidated results show a net profit, which is the key point investors should track in the detailed financial numbers.